Abstract

BackgroundGout is the most common inflammatory arthritis in humans; is caused by deposition of monosodium urate (MSU) crystals within and around joints. Left untreated, a more chronic course may develop,...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Emerging therapeutics for acute and chronic gout
Michael A Becker ... Saima Chohan
-
Michael A Becker, et. al.Michael A Becker ... Saima Chohan
01 Jul 2013
THU0449 Evidence based development of criteria for complete response in patients with chronic refractory gout
P Khanna ... N Schlesinger
Annals of the Rheumatic Diseases | VOL. 76
P Khanna, et. al.P Khanna ... N Schlesinger
01 Jun 2017
Effects of urate-lowering therapy on inflammatory responses, gout flares occurances, and the achieved target rate of serum uric acid in acute gout
...
Chinese Journal of Endocrinology and Metabolism | VOL. 35
, et. al. ...
25 Jun 2019
Difficult-to-Treat Gouty Arthritis
Naomi Schlesinger
Drugs | VOL. 71
Naomi SchlesingerNaomi Schlesinger
01 Jul 2011
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers